Literature DB >> 12127085

Comparison of matrix metalloproteinase expression during Wallerian degeneration in the central and peripheral nervous systems.

P M Hughes1, G M A Wells, V H Perry, M C Brown, K M Miller.   

Abstract

The matrix metalloproteinases (MMPs) are a large family of zinc-dependent enzymes which are able to degrade the protein components of the extracellular matrix. They can be placed into subgroups based on structural similarities and substrate specificity. Aberrant expression of these destructive enzymes has been implicated in the pathogenesis of immune-mediated neuroinflammatory disorders. In this study we investigate the involvement of MMPs, from each subgroup, in Wallerian degeneration in both the central and peripheral nervous systems. Wallerian degeneration describes the process initiated by transection of a nerve fibre and entails the degradation and removal of the axon and myelin from the distal stump. A similar degenerative process occurs as the final shared pathway contributing to most common neuropathies. MMP expression and localisation in the peripheral nervous system are compared with events in the CNS during Wallerian degeneration. Within 3 days after axotomy in the peripheral nervous system, MMP-9, MMP-7 and MMP-12 are elevated. These MMPs are produced by Schwann cells, endothelial cells and macrophages. The temporospatial expression of activated MMP-9 correlates with breakdown of the blood-nerve barrier. In the CNS, 1 week after optic nerve crush, four MMPs are induced and primarily localised to astrocytes, not microglia or oligodendrocytes. In the degenerating optic nerve, examined at later time points (4, 8, 12 and 18 weeks), MMP expression was down-regulated. The absence of MMPs in oligodendrocytes and mononuclear phagocytes during Wallerian degeneration may contribute to the slower removal of myelin debris observed in the CNS. The low level of the inactive pro-form of MMP-9 in the degenerating optic nerve may explain why the blood-brain barrier remains intact, while the blood-nerve barrier is rapidly broken down. We conclude that the difference in the level of expression, activation state and cellular distribution of MMPs may contribute to the different sequence of events observed during Wallerian degeneration in the peripheral compared to the CNS. Copyright 2002 IBRO

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12127085     DOI: 10.1016/s0306-4522(02)00183-5

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  23 in total

1.  Peak in matrix metaloproteinases-2 levels observed during recovery from olfactory nerve injury.

Authors:  Richard M Costanzo; Lisa A Perrino
Journal:  Neuroreport       Date:  2008-02-12       Impact factor: 1.837

2.  TNFalpha-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve.

Authors:  Veronica I Shubayev; Mila Angert; Jennifer Dolkas; W Marie Campana; Kai Palenscar; Robert R Myers
Journal:  Mol Cell Neurosci       Date:  2005-11-16       Impact factor: 4.314

3.  Matrix metalloproteinase inhibition enhances the rate of nerve regeneration in vivo by promoting dedifferentiation and mitosis of supporting schwann cells.

Authors:  Huaqing Liu; Youngsoon Kim; Sharmila Chattopadhyay; Igor Shubayev; Jennifer Dolkas; Veronica I Shubayev
Journal:  J Neuropathol Exp Neurol       Date:  2010-04       Impact factor: 3.685

Review 4.  The neuroimmunology of degeneration and regeneration in the peripheral nervous system.

Authors:  A DeFrancesco-Lisowitz; J A Lindborg; J P Niemi; R E Zigmond
Journal:  Neuroscience       Date:  2014-09-19       Impact factor: 3.590

5.  Early inflammatory profiling of schwannoma cells induced by lipopolysaccharide.

Authors:  Marcela Kohoutková; Andrea Korimová; Václav Brázda; Jiří Kohoutek; Petr Dubový
Journal:  Histochem Cell Biol       Date:  2017-07-28       Impact factor: 4.304

6.  Acellular nerve allografts in peripheral nerve regeneration: a comparative study.

Authors:  Amy M Moore; Matthew MacEwan; Katherine B Santosa; Kristofer E Chenard; Wilson Z Ray; Daniel A Hunter; Susan E Mackinnon; Philip J Johnson
Journal:  Muscle Nerve       Date:  2011-06-09       Impact factor: 3.217

7.  Cytokine regulation of MMP-9 in peripheral glia: implications for pathological processes and pain in injured nerve.

Authors:  Sharmila Chattopadhyay; Robert R Myers; Julie Janes; Veronica Shubayev
Journal:  Brain Behav Immun       Date:  2006-12-26       Impact factor: 7.217

8.  An inhibitor of serine proteases, neuroserpin, acts as a neuroprotective agent in a mouse model of neurodegenerative disease.

Authors:  Yannick Simonin; Yves Charron; Peter Sonderegger; Jean-Dominique Vassalli; Ann C Kato
Journal:  J Neurosci       Date:  2006-10-11       Impact factor: 6.167

9.  Matrix metalloproteinase-14 both sheds cell surface neuronal glial antigen 2 (NG2) proteoglycan on macrophages and governs the response to peripheral nerve injury.

Authors:  Tasuku Nishihara; Albert G Remacle; Mila Angert; Igor Shubayev; Sergey A Shiryaev; Huaqing Liu; Jennifer Dolkas; Andrei V Chernov; Alex Y Strongin; Veronica I Shubayev
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

10.  MMPs initiate Schwann cell-mediated MBP degradation and mechanical nociception after nerve damage.

Authors:  Hideo Kobayashi; Sharmila Chattopadhyay; Kinshi Kato; Jennifer Dolkas; Shin-Ichi Kikuchi; Robert R Myers; Veronica I Shubayev
Journal:  Mol Cell Neurosci       Date:  2008-09-05       Impact factor: 4.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.